XML 65 R55.htm IDEA: XBRL DOCUMENT v3.23.3
Net Loss Per Share Attributable to Adaptive Biotechnologies Corporation Common Shareholders - Computation of the Basic and Diluted Net Loss Per Share Attributable to Common Shareholders (Details) - USD ($)
$ / shares in Units, $ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Earnings Per Share [Abstract]        
Net loss attributable to Adaptive Biotechnologies Corporation $ (50,300) $ (45,281) $ (155,809) $ (160,063)
Weighted-average shares used in computing net loss per share attributable to Adaptive Biotechnologies Corporation common shareholders, basic 144,704,868 142,928,654 144,208,940 142,334,342
Net loss per share attributable to Adaptive Biotechnologies Corporation common shareholders, basic $ (0.35) $ (0.32) $ (1.08) $ (1.12)
Weighted-average shares used in computing net loss per share attributable to Adaptive Biotechnologies Corporation common shareholders, diluted 144,704,868 142,928,654 144,208,940 142,334,342
Net loss per share attributable to Adaptive Biotechnologies Corporation common shareholders, diluted $ (0.35) $ (0.32) $ (1.08) $ (1.12)